Neil Goldenberg, M.D., Ph.D.

Director of Research and Chief Research Officer

Dr. Goldenberg was named director of research at All Children's Hospital Johns Hopkins Medicine in July 2012 as well as chief research officer of the All Children's Research Institute and director of the new Clinical and Translational Research Organization at Johns Hopkins All Children's Hospital. He is an associate professor of pediatrics and medicine at the Johns Hopkins University School of Medicine.

Dr. Goldenberg is principal investigator for both the iPICS (Institution-wide Prospective Inception Cohort Study of Individuals with Childhood-Onset Acute and Chronic Health Conditions) and PREDICT (Prospective Research on Early Determinants of Illness and Children's Health Trajectories) studies at Johns Hopkins All Children's Hospital. Both studies unite physician-scientists in St. Petersburg and Baltimore in searching for biomarkers to improve the diagnosis and treatment of serious diseases and gain insights about the role of genetic, epigenetic and environmental factors that influence development of disease.

Prior to joining Johns Hopkins All Children's Hospital, Goldenberg was on the faculty of the University of Colorado School of Medicine and served as director of the Children's Clinical Research Organization and co-director of the pediatric thrombosis and stroke programs at Children's Hospital Colorado. He also served as director of the Department of Clinical Science and Safety at CPC Clinical Research and associate center director and director of clinical research for the Mountain States Regional Hemophilia and Thrombosis Center. He holds a Ph.D. in Clinical Investigation from the University of Colorado.

In 2012, Dr. Goldenberg completed a five-year Career Development Award from the NIH/National Heart, Lung and Blood Institute for clinical investigation in pediatric thrombosis. He has held additional research grants from the American Society of Hematology, the Hemophilia and Thrombosis Research Society and the National Hemophilia Foundation. He is the principal investigator, steering committee chair or data and safety monitoring committee chair for several NIH- and industry-sponsored multicenter clinical trials, and has co-authored international clinical and clinical research guidelines.

Dr. Goldenberg is director of the pediatric thrombosis program at Johns Hopkins All Children's Hospital and is co-director of the pediatric stroke program. He also leads the Prospective Multicenter Evaluation of the Duration of Therapy for Thrombosis in Children (known as KIDS-DOTT), a study that involves more than two dozen medical institutions.